The global pyrogen testing market size reached US$ 1.2 Billion in 2022. Looking forward, the market is expected to reach US$ 2.2 Billion by 2028, exhibiting a growth rate (CAGR) of 10.63% during 2022-2028.
Pyrogen testing is conducted to detect both endotoxin and non-endotoxin pyrogenic contaminants in aqueous parenteral. It assists in ensuring the safety of the parenteral pharmaceutical product and medical device and avoiding life-threatening diseases and fatal endotoxic shock induced by pyrogenic substances. Some of the commonly utilized methods of pyrogen testing include limulus amebocyte lysate (LAL) test, recombinant factor C (rFC) test, rabbit pyrogen test (RPT), and monocyte activation test (MAT). At present, its demand is escalating across the globe as it is robust, sensitive, and scalable.
Pyrogen testing is conducted to detect both endotoxin and non-endotoxin pyrogenic contaminants in aqueous parenteral. It assists in ensuring the safety of the parenteral pharmaceutical product and medical device and avoiding life-threatening diseases and fatal endotoxic shock induced by pyrogenic substances. Some of the commonly utilized methods of pyrogen testing include limulus amebocyte lysate (LAL) test, recombinant factor C (rFC) test, rabbit pyrogen test (RPT), and monocyte activation test (MAT). At present, its demand is escalating across the globe as it is robust, sensitive, and scalable.
Pyrogen Testing Market Trends
The flourishing pharmaceutical and biotechnology industries around the world represent one of the key factors bolstering the growth of the market. Pyrogen testing finds extensive applications in these industries for the safe development and release of infection-free products at a cost-effective price. It is also utilized for determining microbes or the presence of metabolites in drugs during the manufacturing process. Moreover, the testing aids in improving the management of infectious diseases by determining the disease severity, recovery, and sequelae. As a result, it is employed in the production of coronavirus disease (COVID-19) vaccines worldwide. This, along with the increasing prevalence of chronic ailments, such as heart diseases, cancer, and diabetes, is positively influencing the market. Furthermore, leading players are introducing technologically advanced and cost-effective pyrogen testing techniques that provide a more relevant prediction of pyrogenic activity compared to the traditional methods, which is creating a favorable market outlook. Besides this, the launch of the new therapeutics and continuous funding of research and development (R&D) activities by manufacturing companies and governing agencies of numerous countries is acting as another major growth-inducing factor.Key Market Segmentation
This research provides an analysis of the key trends in each sub-segment of the global pyrogen testing market report, along with forecasts at the global, regional and country level from 2023-2028. The report has categorized the market based on product, test type and application.Breakup by Product:
- Instruments
- Kits and Reagents
- Services
Breakup by Test Type:
- In-vitro Tests
- LAL Tests
- Rabbit Tests
Breakup by Application:
- Pharmaceutical and Biologics
- Medical Devices
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Latin America
- Brazil
- Mexico
- Middle East and Africa
Competitive Landscape
The competitive landscape of the industry has also been examined along with the profiles of the key players being Charles River Laboratories International Inc., Ellab A/S, Fujifilm Wako Pure Chemical Corporation (Fujifilm Holdings Corporation), Lonza Group AG, Merck KGaA, Microcoat Biotechnologie GmbH, Nelson Laboratories LLC (Sotera Health), North American Science Associates Inc., Pacific Biolabs Inc., Sanquin, Thermo Fisher Scientific Inc, Toxikon Corporation and Wuxi Apptec.Key Questions Answered in This Report:
- How has the global pyrogen testing market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global pyrogen testing market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the test type?
- What is the breakup of the market based on the application?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global pyrogen testing market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface3 Executive Summary11 Value Chain Analysis13 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Pyrogen Testing Market
6 Market Breakup by Product
7 Market Breakup by Test Type
8 Market Breakup by Application
9 Market Breakup by Region
10 SWOT Analysis
12 Porters Five Forces Analysis
14 Competitive Landscape
Companies Mentioned
- Charles River Laboratories International Inc.
- Ellab A/S
- Fujifilm Wako Pure Chemical Corporation (Fujifilm Holdings Corporation)
- Lonza Group AG
- Merck KGaA
- Microcoat Biotechnologie GmbH
- Nelson Laboratories LLC (Sotera Health)
- North American Science Associates Inc.
- Pacific Biolabs Inc.
- Sanquin
- Thermo Fisher Scientific Inc
- Toxikon Corporation
- Wuxi Apptec.
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 141 |
Published | November 2023 |
Forecast Period | 2022 - 2028 |
Estimated Market Value ( USD | $ 1.2 Billion |
Forecasted Market Value ( USD | $ 2.2 Billion |
Compound Annual Growth Rate | 10.6% |
Regions Covered | Global |
No. of Companies Mentioned | 13 |